Skip to main content
Clinical Trials/CTRI/2022/01/039806
CTRI/2022/01/039806
Recruiting
Phase 3

Efficacy of repetitive transcranial magnetic stimulation in children and adolescents (5-18 years) with generalised dystonia :A randomised sham controlled trial

Child Neurology Division0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Child Neurology Division
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Child Neurology Division

Eligibility Criteria

Inclusion Criteria

  • 1\.Children with age between 5 to 18 years of either sex.
  • 2\.Presence of generalized dystonia
  • 3\.On stable antidystonic pharmacotherapy and physiotherapy for atleast 3 months
  • 4\. BFMDRS\-M score of 52 or more

Exclusion Criteria

  • Primary Exclusion Criteria
  • 1\.Children diagnosed with progressive neurometabolic or neurodegenerative disorder on the basis of course of illness, neuroimaging and standard diagnostic evaluation.
  • 2\.Children with unilateral dystonia
  • 3\.Children with uncontrolled epilepsy defined as 4 or more seizures in last 6 months
  • 4\.Children with metallic implants anywhere in the body.
  • 5\.Children who underwent DBS/ pallidotomy.
  • 6\.Parents refusing consent for enrolment in the study.
  • Secondary Exclusion Criteria (to be applied at the end of observation phase I)
  • 1\.Change in antidystonia, antipsychotic or antiseizure medications during the observation period
  • 2\.Occurrence of seizure during the observation period

Outcomes

Primary Outcomes

Not specified

Similar Trials